How do single, dual, and triple receptor agonists compare in metabolic research? This guide breaks down the pharmacology of GLP-1, GLP-1/GIP, and GLP-1/GIP/glucagon receptor agonists, including key preclinical findings and mechanistic differences.
More-
GLP-1 Single vs. Dual vs. Triple Receptor Agonists: A Research Comparison
-
Comparative Receptor Binding Affinities of GLP-1 Agonists: GLP1-S, GLP2-T, and GLP3-R
A comparative review of receptor binding kinetics, cryo-EM structural data, and signaling bias profiles for GLP1-S, GLP2-T, and GLP3-R across GLP-1, GIP, and glucagon receptors. This analysis covers radioligand displacement assays, cAMP accumulation experiments, and molecular design principles governing incretin receptor pharmacology. For research purposes only.
More -
MOTS-c Peptide: Can It Improve Mitochondrial Health in GLP1-S Users?
Mitochondrial health is the secret sauce behind energy, metabolic-health, insulin-sensitivity, and even how we age—but can the MOTS-c peptide help GLP1-S users take their fitness, exercise recovery, and longevity to the next level? Let’s explore how this unique peptide could help supercharge your cellular energy and unlock new potential for metabolic-health.
More